206 related articles for article (PubMed ID: 25908766)
1. Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus.
Akinkuolie AO; Pradhan AD; Buring JE; Ridker PM; Mora S
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1544-50. PubMed ID: 25908766
[TBL] [Abstract][Full Text] [Related]
2. A novel protein glycan biomarker and future cardiovascular disease events.
Akinkuolie AO; Buring JE; Ridker PM; Mora S
J Am Heart Assoc; 2014 Sep; 3(5):e001221. PubMed ID: 25249300
[TBL] [Abstract][Full Text] [Related]
3. Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk.
Lawler PR; Akinkuolie AO; Chandler PD; Moorthy MV; Vandenburgh MJ; Schaumberg DA; Lee IM; Glynn RJ; Ridker PM; Buring JE; Mora S
Circ Res; 2016 Apr; 118(7):1106-15. PubMed ID: 26951635
[TBL] [Abstract][Full Text] [Related]
4. GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study.
Connelly MA; Gruppen EG; Wolak-Dinsmore J; Matyus SP; Riphagen IJ; Shalaurova I; Bakker SJ; Otvos JD; Dullaart RP
Clin Chim Acta; 2016 Jan; 452():10-7. PubMed ID: 26549655
[TBL] [Abstract][Full Text] [Related]
5. Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality.
Chandler PD; Akinkuolie AO; Tobias DK; Lawler PR; Li C; Moorthy MV; Wang L; Duprez DA; Jacobs DR; Glynn RJ; Otvos J; Connelly MA; Post WS; Ridker PM; Manson JE; Buring JE; Lee IM; Mora S
PLoS One; 2016; 11(11):e0165615. PubMed ID: 27902713
[TBL] [Abstract][Full Text] [Related]
6. Novel Protein Glycan-Derived Markers of Systemic Inflammation and C-Reactive Protein in Relation to Glycemia, Insulin Resistance, and Insulin Secretion.
Lorenzo C; Festa A; Hanley AJ; Rewers MJ; Escalante A; Haffner SM
Diabetes Care; 2017 Mar; 40(3):375-382. PubMed ID: 28031420
[TBL] [Abstract][Full Text] [Related]
7. Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial.
Akinkuolie AO; Glynn RJ; Padmanabhan L; Ridker PM; Mora S
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27413042
[TBL] [Abstract][Full Text] [Related]
8. Association of the Novel Inflammatory Marker GlycA and Incident Heart Failure and Its Subtypes of Preserved and Reduced Ejection Fraction: The Multi-Ethnic Study of Atherosclerosis.
Jang S; Ogunmoroti O; Ndumele CE; Zhao D; Rao VN; Fashanu OE; Tibuakuu M; Otvos JD; Benson EM; Ouyang P; Michos ED
Circ Heart Fail; 2020 Aug; 13(8):e007067. PubMed ID: 32762458
[TBL] [Abstract][Full Text] [Related]
9. A pro-inflammatory glycoprotein biomarker is associated with lower bilirubin in metabolic syndrome.
Dullaart RP; Gruppen EG; Connelly MA; Lefrandt JD
Clin Biochem; 2015 Nov; 48(16-17):1045-7. PubMed ID: 26129880
[TBL] [Abstract][Full Text] [Related]
10. Associations of ideal cardiovascular health with GlycA, a novel inflammatory marker: The Multi-Ethnic Study of Atherosclerosis.
Benson EA; Tibuakuu M; Zhao D; Akinkuolie AO; Otvos JD; Duprez DA; Jacobs DR; Mora S; Michos ED
Clin Cardiol; 2018 Nov; 41(11):1439-1445. PubMed ID: 30452775
[TBL] [Abstract][Full Text] [Related]
11. GlycA, a biomarker of inflammatory glycoproteins, is more closely related to the leptin/adiponectin ratio than to glucose tolerance status.
Dullaart RP; Gruppen EG; Connelly MA; Otvos JD; Lefrandt JD
Clin Biochem; 2015 Aug; 48(12):811-4. PubMed ID: 25977069
[TBL] [Abstract][Full Text] [Related]
12. A novel protein glycan biomarker and LCAT activity in metabolic syndrome.
Gruppen EG; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
Eur J Clin Invest; 2015 Aug; 45(8):850-9. PubMed ID: 26081900
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of GlycA, a pro-inflammatory glycoprotein biomarker, associate with an increased risk of microvascular complications in patients with type 2 diabetes (Zodiac-62).
Bourgonje AR; van der Vaart A; Gruppen EG; van Goor H; Bakker SJL; Connelly MA; van Dijk PR; Dullaart RPF
Endocrine; 2023 May; 80(2):312-316. PubMed ID: 36757630
[TBL] [Abstract][Full Text] [Related]
14. Biomarker Glycoprotein Acetyls Is Associated With the Risk of a Wide Spectrum of Incident Diseases and Stratifies Mortality Risk in Angiography Patients.
Kettunen J; Ritchie SC; Anufrieva O; Lyytikäinen LP; Hernesniemi J; Karhunen PJ; Kuukasjärvi P; Laurikka J; Kähönen M; Lehtimäki T; Havulinna AS; Salomaa V; Männistö S; Ala-Korpela M; Perola M; Inouye M; Würtz P
Circ Genom Precis Med; 2018 Nov; 11(11):e002234. PubMed ID: 30571186
[TBL] [Abstract][Full Text] [Related]
15. Association Between Smoking and Serum GlycA and High-Sensitivity C-Reactive Protein Levels: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Kianoush S; Bittencourt MS; Lotufo PA; Bensenor IM; Jones SR; DeFilippis AP; Toth PP; Otvos JD; Tibuakuu M; Hall ME; Harada PHN; Blaha MJ
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28838917
[TBL] [Abstract][Full Text] [Related]
16. Association of Plasma Branched-Chain Amino Acid With Biomarkers of Inflammation and Lipid Metabolism in Women.
Hamaya R; Mora S; Lawler PR; Cook NR; Ridker PM; Buring JE; Lee IM; Manson JE; Tobias DK
Circ Genom Precis Med; 2021 Aug; 14(4):e003330. PubMed ID: 34264743
[TBL] [Abstract][Full Text] [Related]
17. GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function.
Gruppen EG; Riphagen IJ; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
PLoS One; 2015; 10(9):e0139057. PubMed ID: 26398105
[TBL] [Abstract][Full Text] [Related]
18. Plasma Placental Growth Factor Concentrations Are Elevated Well in Advance of Type 2 Diabetes Mellitus Onset: Prospective Data From the WHS.
Duran EK; Cook NR; Bobadilla M; Kim E; Manson JE; Buring JE; Ridker PM; Pradhan AD
J Am Heart Assoc; 2019 Aug; 8(15):e012790. PubMed ID: 31322059
[TBL] [Abstract][Full Text] [Related]
19. Effects of regular endurance exercise on GlycA: Combined analysis of 14 exercise interventions.
Barber JL; Kraus WE; Church TS; Hagberg JM; Thompson PD; Bartlett DB; Beets MW; Earnest CP; Huffman KM; Landers-Ramos RQ; Leon AS; Rao DC; Seip RL; Skinner JS; Slentz CA; Wilund KR; Bouchard C; Sarzynski MA
Atherosclerosis; 2018 Oct; 277():1-6. PubMed ID: 30170218
[TBL] [Abstract][Full Text] [Related]
20. A Novel Protein Glycan-Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality.
McGarrah RW; Kelly JP; Craig DM; Haynes C; Jessee RC; Huffman KM; Kraus WE; Shah SH
Clin Chem; 2017 Jan; 63(1):288-296. PubMed ID: 27811210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
